However, significant gaps remain in elucidating the downstream signaling pathways of MCAM in different cancer types, particularly melanoma and breast cancer (Wang et al.2020; Mannion et al.2023; Balcioglu et al.2024; Braun et al.2025). This evidence concerns the gene MCAM and melanoma.